Cargando…
The improved anticancer effects of Bortezomib-loaded hollow mesoporous silica nanospheres on lymphoma development
As the first clinical proteasome inhibitor, Bortezomib (BTZ) has been reported to improve the outcome of lymphoma. However, due to the unstable property, low bioavailability, and hydrophobic properties of BTZ, it is needed to develop effective drug delivery systems to deliver BTZ into targeted cells...
Autores principales: | Shen, Jie, Wang, Ruihuan, Wang, Qing, Zhang, Minjuan, Liu, Chunyan, Tao, Zhenxia, Su, Guohong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835069/ https://www.ncbi.nlm.nih.gov/pubmed/33290262 http://dx.doi.org/10.18632/aging.202146 |
Ejemplares similares
-
Delivery of Natural Agents by Means of Mesoporous Silica Nanospheres as a Promising Anticancer Strategy
por: AbouAitah, Khaled, et al.
Publicado: (2021) -
Red Blood Cell Membrane Bioengineered Zr-89 Labelled Hollow Mesoporous Silica Nanosphere for Overcoming Phagocytosis
por: Lee, Jun Young, et al.
Publicado: (2019) -
Mesoporous multi-shelled hollow resin nanospheres with ultralow thermal conductivity
por: Yuan, Ruilin, et al.
Publicado: (2022) -
Iron-Based Oxygen
Scavengers on Mesoporous Silica
Nanospheres
por: He, Yanling, et al.
Publicado: (2023) -
Enhancement of Alkaline Protease Activity and Stability via Covalent Immobilization onto Hollow Core-Mesoporous Shell Silica Nanospheres
por: Ibrahim, Abdelnasser Salah Shebl, et al.
Publicado: (2016)